← Eichor
Study identifier: NCT06097000 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Study of the Safety and Efficacy of Intelligent Powered Exoskeletons in Postoperative Spinal Rehabilitation

Condition: Exoskeleton Device  ·  Sponsor: Xuanwu Hospital, Beijing

PhaseNA
Planned participants80
Who can joinAll sexes, 18 Years to 70 Years
Healthy volunteersNo

About this study

Systematic and professional rehabilitation training is generally effective for patients with lower limb dyskinesia, but most of them lose the chance of recovery due to failure to receive systematic rehabilitation treatment. Our team has developed an intelligent power armor for patients with lower limb motor dysfunction, which can assist patients to complete high-quality rehabilitation training. In order to evaluate the safety and efficacy of the Smart Power Armor for post-surgical spine patients, and to provide data support for a confirmatory clinical study, we designed a single-center, prospective, randomized controlled study to compare the level of recovery of lower limb motor function in patients with different rehabilitation strategies.

This description comes directly from the study's public registry record.

Talk to the study team

Wanru Duan  ·  13581803400  ·  duanwanru@xwhosp.org

Always discuss trial participation with your own doctor first.

Locations (1)

Intelligent Powered ExoskeletonBeijing, Beijing Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06097000